tetano
Editor, Senior Moderator
Cell Commun Signal
. 2023 Mar 2;21(1):44.
doi: 10.1186/s12964-023-01044-0.
SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis
A Ram Lee[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Jin Seok Woo[SUP] #[/SUP][SUP] 1 2 [/SUP], Seon-Yeong Lee[SUP] 1 2 [/SUP], Yeon Su Lee[SUP] 1 2 3 [/SUP], Jooyeon Jung[SUP] 1 2 [/SUP], Chae Rim Lee[SUP] 1 2 3 [/SUP], Sung-Hwan Park[SUP] 4 [/SUP], Mi-La Cho[SUP] 5 6 7 8 [/SUP]
Affiliations
Abstract
Background: Coronavirus disease 2019 (COVID-19) induces inflammation, autoantibody production, and thrombosis, which are common symptoms of autoimmune diseases, including rheumatoid arthritis (RA). However, the effect of COVID-19 on autoimmune disease is not yet fully understood.
Methods: This study was performed to investigate the effects of COVID-19 on the development and progression of RA using a collagen-induced arthritis (CIA) animal model. Human fibroblast-like synoviocytes (FLS) were transduced with lentivirus carrying the SARS-CoV-2 spike protein gene in vitro, and the levels of inflammatory cytokine and chemokine expression were measured. For in vivo experiments, CIA mice were injected with the gene encoding SARS-CoV-2 spike protein, and disease severity, levels of autoantibodies, thrombotic factors, and inflammatory cytokine and chemokine expression were assessed. In the in vitro experiments, the levels of inflammatory cytokine and chemokine expression were significantly increased by overexpression of SARS-CoV-2 spike protein in human FLS.
Results: The incidence and severity of RA in CIA mice were slightly increased by SARS-CoV-2 spike protein in vivo. In addition, the levels of autoantibodies and thrombotic factors, such as anti-CXC chemokine ligand 4 (CXCL4, also called PF4) antibodies and anti-phospholipid antibodies were significantly increased by SARS-CoV-2 spike protein. Furthermore, tissue destruction and inflammatory cytokine level in joint tissue were markedly increased in CIA mice by SARS-CoV-2 spike protein.
Conclusions: The results of the present study suggested that COVID-19 accelerates the development and progression of RA by increasing inflammation, autoantibody production, and thrombosis. Video Abstract.
Keywords: Autoimmune disease; Coronavirus disease 2019 (COVID-19); Inflammation; Rheumatoid arthritis (RA); Thrombosis.
. 2023 Mar 2;21(1):44.
doi: 10.1186/s12964-023-01044-0.
SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis
A Ram Lee[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Jin Seok Woo[SUP] #[/SUP][SUP] 1 2 [/SUP], Seon-Yeong Lee[SUP] 1 2 [/SUP], Yeon Su Lee[SUP] 1 2 3 [/SUP], Jooyeon Jung[SUP] 1 2 [/SUP], Chae Rim Lee[SUP] 1 2 3 [/SUP], Sung-Hwan Park[SUP] 4 [/SUP], Mi-La Cho[SUP] 5 6 7 8 [/SUP]
Affiliations
- PMID: 36864432
- DOI: 10.1186/s12964-023-01044-0
Abstract
Background: Coronavirus disease 2019 (COVID-19) induces inflammation, autoantibody production, and thrombosis, which are common symptoms of autoimmune diseases, including rheumatoid arthritis (RA). However, the effect of COVID-19 on autoimmune disease is not yet fully understood.
Methods: This study was performed to investigate the effects of COVID-19 on the development and progression of RA using a collagen-induced arthritis (CIA) animal model. Human fibroblast-like synoviocytes (FLS) were transduced with lentivirus carrying the SARS-CoV-2 spike protein gene in vitro, and the levels of inflammatory cytokine and chemokine expression were measured. For in vivo experiments, CIA mice were injected with the gene encoding SARS-CoV-2 spike protein, and disease severity, levels of autoantibodies, thrombotic factors, and inflammatory cytokine and chemokine expression were assessed. In the in vitro experiments, the levels of inflammatory cytokine and chemokine expression were significantly increased by overexpression of SARS-CoV-2 spike protein in human FLS.
Results: The incidence and severity of RA in CIA mice were slightly increased by SARS-CoV-2 spike protein in vivo. In addition, the levels of autoantibodies and thrombotic factors, such as anti-CXC chemokine ligand 4 (CXCL4, also called PF4) antibodies and anti-phospholipid antibodies were significantly increased by SARS-CoV-2 spike protein. Furthermore, tissue destruction and inflammatory cytokine level in joint tissue were markedly increased in CIA mice by SARS-CoV-2 spike protein.
Conclusions: The results of the present study suggested that COVID-19 accelerates the development and progression of RA by increasing inflammation, autoantibody production, and thrombosis. Video Abstract.
Keywords: Autoimmune disease; Coronavirus disease 2019 (COVID-19); Inflammation; Rheumatoid arthritis (RA); Thrombosis.